A B56γ mutation in lung cancer disrupts the p53-dependent tumor-suppressor function of protein phosphatase 2A

Oncogene

Volumn 29, Issue 27, 2010, Pages 3933-3941

  Shouse, G P ^a   Nobumori, Y ^a   Liu, X ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

B56g; lung cancer; p53; PP2A; Thr55 phosphorylation

Indexed keywords

B56GAMMA PROTEIN; P21 ACTIVATED KINASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; PHOSPHOPROTEIN PHOSPHATASE 2; PPP2R5C PROTEIN, HUMAN;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL TRANSFORMATION; DNA DAMAGE; GENE DISRUPTION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPRECIPITATION; LUNG CANCER; MUTANT; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; CHEMISTRY; ENZYMOLOGY; GENETICS; LUNG TUMOR; METABOLISM; MUTATION; PATHOLOGY; PHOSPHORYLATION; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; LUNG NEOPLASMS; MUTATION; PHOSPHORYLATION; PROTEIN PHOSPHATASE 2; PROTEIN STRUCTURE, TERTIARY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77954541457     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.161     Document Type: Article

References (27)

1. Arnold H, Sears R. (2006). Protein phosphatase 2A regulatory subunit B56a associates with c-Myc and negatively regulates c-Myc accumulation. Mol Cell Biol 26: 2832-2844.
2. Bennin D, Don A, Brake T, McKenzie J, Rosenbaum H, Ortiz L et al. (2002). Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B' subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest. J Biol Chem 277: 27449-27467.
3. Bode A, Dong Z. (2004). Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 4: 793-805.
4. Chen W, Arroyo J, Timmons J, Possemato R, Hahn W. (2005). Cancer-associated PP2A Aa subunits induce functional haploinsuf-ficiency and tumorigenicity. Cancer Res 85: 8183-8192.
5. Chen W, Possemato R, Campbell K, Plattner C, Pallas D, Hahn W. (2004). Identification of specific PP2A complexes involved in human cell transformation. Cancer Cell 5: 127-136.
6. Cho U, Xu W. (2006). Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme. Nature 445: 53-57.
7. Eichorn P, Creyghton M, Bernards R. (2009). Protein phosphatase 2A regulatory subunits and cancer. Biochim Biophys Acta 1795: 1-15.
8. Esplin E, Ramos P, Martinez B, Tomlinson G, Mumby M, Evans G. (2006). The Glycine 90 to Aspartate alteration in the Ab subunit of PP2A (PPP2R1B) associates with breast cancer and causes a deficit in protein function. Genes Chromosomes Cancer 45: 182-190.
9. Forester C, Maddox J, Louis J, Goris J, Virshup D. (2007). Control of mitotic exit by PP2A regulation of Cdc25C and Cdk1. Proc Natl Acad Sci USA 104: 19867-19872.
10. Grochola L, Vazquez A, Bond E, Wurl P, Taubert H, Muller T et al. (2009). Recent natural selection identifies a genetic variant in a regulator subunit of protein phosphatase 2A that associates with altered cancer risk and survival. Clin Cancer Res 15: 6301-6308.
11. Janssens V, Goris J. (2001). Protein Phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signaling. Biochem J 353: 417-439.
12. Kruse J, Gu W. (2009). Modes of p53 regulation. Cell 137: 609-622.
13. Letourneux C, Rocher G, Porteu F. (2006). B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK. EMBO J 25: 727-738.
14. Li H, Cai X, Shouse G, Piluso L, Liu X. (2007). A specific PP2A regulatory subunit, B56g, mediates DNA damage-induced dephosphorylation of p53 at Thr55. EMBO 26: 402-411.
15. Margolis S, Perry J, Forester C, Nutt L, Guo M, Jardim M et al. (2006). Role for the PP2A/B56d phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis. Cell 127: 759-763.
16. Neto E, Correa R, Verjovski-Almeida S, Briones M, Nagai M, da Silva W et al. (2006). Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. Proc Natl Acad Sci USA 97: 3491-3496.
17. Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian S, Hainaut P et al. (2007). Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 6: 622-629.
18. Riedel C, Katis V, Katou Y, Mori S, Itoh T, Helmhart W et al. (2006). Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis I. Nature 441: 53-61.
19. Ruediger R, Pham H, Walter G. (2001a). Alterations in protein phos-phatase 2A subunit interaction in human carcinomas of the lung and colon with mutations in the Ab subunit gene. Oncogene 20: 1892-1899. (Pubitemid 32458699)
20. Ruediger R, Pham H, Walter G. (2001b). Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the Aa subunit gene. Oncogene 12: 10-15.
21. Schonthal A. (2001). Role of serine/threonine protein phosphatase 2A in cancer. Cancer Lett 170: 1-13.
22. Shouse G, Cai X, Liu X. (2008). Serine 15 phosphorylation of p53 directs its interaction with B56g and the tumor suppressor activity of B56g-specific protein phosphatase 2A. Mol Cell Biol 28: 448-456.
23. Suzuki Y, Yamashita R, Shirota M, Sakakibara Y, Chiba J, Mizushima-Sugano J et al. (2004). Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions. Genome Res 14: 1711-1718.
24. Virshup D, Shenolikar S. (2009). From promiscuity to precision: protein phosphatases get a makeover. Mol Cell 33: 537-545.
25. Vousden K, Prives C. (2009). Blinded by the light: the growing complexity of p53. Cell 137: 413-431.
26. Wang S, Esplin E, Li J, Huang L, Gazdar A, Minna J et al. (1998). Alterations of the PPP2R1B gene in human lung and colon cancer. Science 282: 284-287.
27. Xu Y, Xing Y, Chen Y, Chao Y, Lin Z, Fan E et al. (2006). Structure of the protein phosphatase 2A holoenzyme. Cell 127: 1239-1251.